MIMEDX to Participate in Upcoming Investor Conferences
Get Alerts MDXG Hot Sheet
Join SI Premium – FREE
MARIETTA, Ga., Dec. 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Mizuho Health Care Conference
Wednesday, December 11, 2024
1:1 sessions | New York, NY
Northland Growth Conference
Thursday, December 12, 2024
1:1 sessions | Virtual
Stifel MedTech West Coast Bus Tour
Thursday, December 12, 2024
1:1 sessions | Palo Alto, CA
Investors interested in meeting with senior management at these events may contact their respective Mizuho, Northland Capital or Stifel representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Globalstar Confirms Successful Launch of All 8 HIBLEO-4 Replacement Satellites
- HII’s Newport News Shipbuilding Completes Successful Acceptance Sea Trials of John F. Kennedy (CVN 79)
- In HelloNation, Family Dental Care Experts Dr. Joseph T. Sumrall and Dr. Gran Sumrall of Warner Robins, GA, Explain Why Cosmetic Dental Changes Focus on Looking Natural
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stifel, MizuhoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share